文献速递放射性药物与辐射防护核素与放射性配体治疗肿瘤 PET/CT

MIRD第30号手册:MIRDfit——用于内照射剂量学的生物分布时间-活度数据拟合工具

MIRD Pamphlet No. 30: MIRDfit-A Tool for Fitting of Biodistribution Time-Activity Data for Internal Dosimetry.
PubMed 文献 · J Nucl Med · 2024-11-01

MIRDfit作为MIRDsoft计划的一部分被开发,用于生物分布数据拟合与内照射剂量评估,提供核医学适用拟合函数、客观最佳拟合选择指标、TIAC不确定度计算、质量控制与数据归档、与MIRDcalc软件集成及基于Excel的友好界面。使用18F-FDG和177Lu-DOTATATE的系列显像研究推导TIAC,与其它软件比较,多数情况下TIAC一致性约在10%以内。MIRDfit已获核医学与分子影像学会MIRD委员会认可,并集成入MIRDsoft免费剂量学软件套件,供免费下载使用。

要点

  • MIRDfit提供核医学适用拟合函数与客观指标指导最佳拟合选择。
  • MIRDfit可计算时间积分活度系数(TIAC)的不确定度。
  • MIRDfit与其它软件在多数情况下TIAC一致性约在10%以内。

核心结论

  • MIRDfit提供生物分布拟合软件解决方案,具备核医学适用拟合函数、客观最佳拟合选择指标、TIAC不确定度计算、质量控制与数据归档、与MIRDcalc集成及基于Excel的友好界面等核心功能。
  • 在大多数情况下,MIRDfit与其它软件获得的TIAC估计值一致性约在10%以内。
  • MIRDfit已获核医学与分子影像学会MIRD委员会认可,并已集成入MIRDsoft免费剂量学软件套件,可在https://mirdsoft.org/免费下载。

研究设计与样本

  • MIRDfit作为MIRDsoft计划的一部分被开发,用于内照射剂量评估中的生物分布拟合。
  • 为验证MIRDfit性能,使用18F-FDG和177Lu-DOTATATE的系列显像研究推导TIAC,并与其它软件获得的TIAC估计值进行比较。

主要发现

  • 在大多数情况下,MIRDfit与其它软件获得的TIAC估计值一致性约在10%以内。

关键数值与推荐

  • MIRDfit提供核医学适用拟合函数、客观最佳拟合选择指标、TIAC不确定度计算、质量控制与数据归档、与MIRDcalc软件集成及基于Excel的友好界面。
  • MIRDfit已获MIRD委员会认可并集成入MIRDsoft免费软件套件,可在https://mirdsoft.org/免费下载。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In nuclear medicine, estimating the number of radioactive decays that occur in a source organ per unit administered activity of a radiopharmaceutical (i.e., the time-integrated activity coefficient [TIAC]) is an essential task within the internal dosimetry workflow. TIAC estimation is commonly derived by least-squares fitting of various exponential models to organ time-activity data (radiopharmaceutical biodistribution). Rarely, however, are methods used to objectively determine the model that best characterizes the data. Additionally, the uncertainty associated with the resultant TIAC is generally not evaluated. As part of the MIRDsoft initiative, MIRDfit has been developed to offer a biodistribution fitting software solution that provides the following essential features and advantages for internal dose assessment: nuclear medicine-appropriate fit functions; objective metrics for guiding best-fit selection; TIAC uncertainty calculation; quality control and data archiving; integration with MIRDcalc software for dose calculation; and a user-friendly Excel-based interface. For demonstration and comparative validation of MIRDfit's performance, TIACs were derived from serial imaging studies involving 18F-FDG and 177Lu-DOTATATE using MIRDfit. These TIACs were then compared with TIAC estimates obtained using other software. In most cases, the TIACs agreed within approximately 10% between MIRDfit and the other software. MIRDfit has been endorsed by the MIRD Committee of the Society of Nuclear Medicine and Molecular Imaging and has been integrated into the MIRDsoft suite of free dosimetry software; it is available for download at no user cost (https://mirdsoft.org/).

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Carter LM, Ocampo Ramos JC, Schuerrle SB, et al. MIRD Pamphlet No. 30: MIRDfit-A Tool for Fitting of Biodistribution Time-Activity Data for Internal Dosimetry. J Nucl Med. 2024. PMID: 39327016. doi:10.2967/jnumed.124.268011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。